Cargando…
The Structural Determinants of Insulin-Like Peptide 3 Activity
Insulin-like peptide 3 (INSL3) is a hormone and/or paracrine factor which is a member of the relaxin peptide family. It has key roles as a fertility regulator in both males and females. The receptor for INSL3 is the leucine rich repeat (LRR) containing G-protein coupled receptor 8 (LGR8) which is no...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356098/ https://www.ncbi.nlm.nih.gov/pubmed/22654853 http://dx.doi.org/10.3389/fendo.2012.00011 |
_version_ | 1782233499447590912 |
---|---|
author | Bathgate, Ross A. D. Zhang, Soude Hughes, Richard A. Rosengren, K. Johan Wade, John D. |
author_facet | Bathgate, Ross A. D. Zhang, Soude Hughes, Richard A. Rosengren, K. Johan Wade, John D. |
author_sort | Bathgate, Ross A. D. |
collection | PubMed |
description | Insulin-like peptide 3 (INSL3) is a hormone and/or paracrine factor which is a member of the relaxin peptide family. It has key roles as a fertility regulator in both males and females. The receptor for INSL3 is the leucine rich repeat (LRR) containing G-protein coupled receptor 8 (LGR8) which is now known as relaxin family peptide receptor 2 (RXFP2). Receptor activation by INSL3 involves binding to the LRRs in the large ectodomain of RXFP2 by residues within the B-chain of INSL3 as well as an interaction with the transmembrane exoloops of the receptor. Although the binding to the LRRs is well characterized the features of the peptide and receptor involved in the exoloop interaction are currently unknown. This study was designed to determine the key INSL3 determinants for RXFP2 activation. A chimeric peptide approach was first utilized to demonstrate that the A-chain is critical for receptor activation. Replacement of the INSL3 A-chain with that from the related peptides INSL5 and INSL6 resulted in complete loss of activity despite only minor changes in binding affinity. Subsequent replacement of specific A-chain residues with those from the INSL5 peptide highlighted that the N-terminus of the A-chain of INSL3 is critical for its activity. Remarkably, replacement of the entire N-terminus with four or five alanine residues resulted in peptides with near native activity suggesting that specific residues are not necessary for activity. Additionally removal of two amino acids at the C-terminus of the A-chain and mutation of Lys-8 in the B-chain also resulted in minor decreases in peptide activity. Therefore we have demonstrated that the activity of the INSL3 peptide is driven predominantly by residues 5–9 in the A-chain, with minor additional contributions from the two C-terminal A-chain residues and Lys-8 in the B-chain. Using this new knowledge, we were able to produce a truncated INSL3 peptide structure which retained native activity, despite having 14 fewer residues than the parent peptide. |
format | Online Article Text |
id | pubmed-3356098 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Frontiers Research Foundation |
record_format | MEDLINE/PubMed |
spelling | pubmed-33560982012-05-31 The Structural Determinants of Insulin-Like Peptide 3 Activity Bathgate, Ross A. D. Zhang, Soude Hughes, Richard A. Rosengren, K. Johan Wade, John D. Front Endocrinol (Lausanne) Endocrinology Insulin-like peptide 3 (INSL3) is a hormone and/or paracrine factor which is a member of the relaxin peptide family. It has key roles as a fertility regulator in both males and females. The receptor for INSL3 is the leucine rich repeat (LRR) containing G-protein coupled receptor 8 (LGR8) which is now known as relaxin family peptide receptor 2 (RXFP2). Receptor activation by INSL3 involves binding to the LRRs in the large ectodomain of RXFP2 by residues within the B-chain of INSL3 as well as an interaction with the transmembrane exoloops of the receptor. Although the binding to the LRRs is well characterized the features of the peptide and receptor involved in the exoloop interaction are currently unknown. This study was designed to determine the key INSL3 determinants for RXFP2 activation. A chimeric peptide approach was first utilized to demonstrate that the A-chain is critical for receptor activation. Replacement of the INSL3 A-chain with that from the related peptides INSL5 and INSL6 resulted in complete loss of activity despite only minor changes in binding affinity. Subsequent replacement of specific A-chain residues with those from the INSL5 peptide highlighted that the N-terminus of the A-chain of INSL3 is critical for its activity. Remarkably, replacement of the entire N-terminus with four or five alanine residues resulted in peptides with near native activity suggesting that specific residues are not necessary for activity. Additionally removal of two amino acids at the C-terminus of the A-chain and mutation of Lys-8 in the B-chain also resulted in minor decreases in peptide activity. Therefore we have demonstrated that the activity of the INSL3 peptide is driven predominantly by residues 5–9 in the A-chain, with minor additional contributions from the two C-terminal A-chain residues and Lys-8 in the B-chain. Using this new knowledge, we were able to produce a truncated INSL3 peptide structure which retained native activity, despite having 14 fewer residues than the parent peptide. Frontiers Research Foundation 2012-02-01 /pmc/articles/PMC3356098/ /pubmed/22654853 http://dx.doi.org/10.3389/fendo.2012.00011 Text en Copyright © 2012 Bathgate, Zhang, Hughes, Rosengren and Wade. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited. |
spellingShingle | Endocrinology Bathgate, Ross A. D. Zhang, Soude Hughes, Richard A. Rosengren, K. Johan Wade, John D. The Structural Determinants of Insulin-Like Peptide 3 Activity |
title | The Structural Determinants of Insulin-Like Peptide 3 Activity |
title_full | The Structural Determinants of Insulin-Like Peptide 3 Activity |
title_fullStr | The Structural Determinants of Insulin-Like Peptide 3 Activity |
title_full_unstemmed | The Structural Determinants of Insulin-Like Peptide 3 Activity |
title_short | The Structural Determinants of Insulin-Like Peptide 3 Activity |
title_sort | structural determinants of insulin-like peptide 3 activity |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356098/ https://www.ncbi.nlm.nih.gov/pubmed/22654853 http://dx.doi.org/10.3389/fendo.2012.00011 |
work_keys_str_mv | AT bathgaterossad thestructuraldeterminantsofinsulinlikepeptide3activity AT zhangsoude thestructuraldeterminantsofinsulinlikepeptide3activity AT hughesricharda thestructuraldeterminantsofinsulinlikepeptide3activity AT rosengrenkjohan thestructuraldeterminantsofinsulinlikepeptide3activity AT wadejohnd thestructuraldeterminantsofinsulinlikepeptide3activity AT bathgaterossad structuraldeterminantsofinsulinlikepeptide3activity AT zhangsoude structuraldeterminantsofinsulinlikepeptide3activity AT hughesricharda structuraldeterminantsofinsulinlikepeptide3activity AT rosengrenkjohan structuraldeterminantsofinsulinlikepeptide3activity AT wadejohnd structuraldeterminantsofinsulinlikepeptide3activity |